TGA Annual Fees To Drop By Five Percent
29th May 17
The Therapeutic Goods Administration (TGA) has advised that the annual charges for most medical devices will drop by 5% for FY2017-18, highlighting the regulator's responsiveness to ADIA's advocacy to reduce business' compliance costs.
Key Issues For The Dental Industry —
The TGA is the nation’s regulator of medical devices (that includes most dental products) and medicines and maintains the Australian Register of Therapeutic Goods (ARTG), the list of products that can be lawfully supplied in Australia. There is an annual charge that business must pay for keeping products on the ARTG.
Following consultation with industry stakeholders, the Australian Government approved a decrease of 4.96% for annual charges for most medical devices as a key component in the FY2017-18 budget for the TGA.
Other TGA fees, such as those for an application audit, will increase by a modest 1.65% for the coming year.
The decrease in most annual fees paid by the dental industry highlights the importance of ADIA’s advocacy at a departmental and parliamentary level to ensure that the TGA operates efficiently and in a way that reduces the dental industry's compliance costs.
ADIA has been a long-standing critic of the standard method used to determine the TGA’s annual fee increase, this being to simply use the average of the Consumer Price Index (CPI) and the Wage Price Index (WPI). That the TGA has used an alternative method in setting most of its annual charges for the year ahead is a clear indication that the regulator has listened and responded to ADIA in setting its budget.
Member Engagement —
On matters associated with dental product regulation the team in the ADIA national office receives advice and guidance from members serving on the ADIA-DRC Dental Regulation Committee. Updates on the research are provided at the quarterly ADIA State Branch Briefings. If your business has an interest in this matter, get involved today.
Further Information —
For further information from ADIA's on matters associated with dental product regulation send an email to email@example.com or telephone 1300 943 094. To keep up to date follow ADIA on Facebook at www.facebook.com/dental.industry or subscribe to the Twitter feed @AusDental.
Currency Of Information & Disclaimer —
This update was issued on 29 May 2017 and please note that changes in circumstances after the publication of material or information may impact upon its accuracy and also change regulatory compliance obligations. The statements, regulatory and technical information contained herein are believed to be accurate and are provided for information purposes only. Readers are responsible for assessing its relevance and verifying the accuracy of the content. To the fullest extent permitted by law, ADIA will not be liable for any loss, damage, cost or expense incurred in relation to or arising as a result of relying on the information presented here.
This publication is available for your use under a Creative Commons Attribution 3.0 Australia licence, with the exception of the ADIA logo, images and where stated.
6th Mar 19
The Therapeutic Goods Administration (TGA) has released an update on Brexit and the implications for therapeutic goods in Australia under any of the possible agreements that could occur.
31st Jan 19
Small businesses will get an extra tax break with the Australian Government extending the instant asset write-off to mid-2020.